肿瘤相关胰蛋白酶抑制物
摘要
肿瘤相关胰蛋白酶抑制物是一种新发现的肿瘤标记物。近年来,在国外临床医学上被广泛用于多种肿瘤的实验诊断、疗效监测和预后评估。对此,本文就其结构、生理功能、理化性质和临床应用作一简要介绍。
出处
《国外医学（临床生物化学与检验学分册）》
2003年第4期197-198,203,共3页
Foreign Medical Sciences(section of Clinical Biochemistry and Laboratory Medicine
参考文献15
-
1Schlott B, Wohnert J, Icke C, et al. Interaction of kazaltype inhibitor domains with serine proteinases: biochemical and structural studies[J]. J Mol Biol,2002,318: 533-546.
-
2Yasuda T, Ohmachi Y. Identification of novel pancreasspecific regulatory sequences in the promoter region of human pancreatic secretory trypsin inhibitor gene[J]. J Biol Chem, 1998,273:34413-34421.
-
3Tramonti G, Ferdeghini M, Donadio C, et al. Renal function and serum concentration of five tumor markers (TATI, SCC, CYFRA 21-1, TPA, and TPS) in patients without evidence of neoplasia [J]. Cancer Detect Prev,2000,24:86-90.
-
4Chen J M, Mercier B, Audrezet MP, et al. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis[J]. J Med Genet,2000,37 : 67-96.
-
5Hirota M, Kuwata K, Ohmuraya M, et al. From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene[J]. J O P, 2003,4: 83-88.
-
6Harkki-Siren P,Sjoberg J, Toivonen J, et al. Clinical outcome and tissue trauma after laparoscopic and abdominal hysterectomy:a randomized controlled study[J]. Acta Obstet Gynecol Scand, 2000,79 : 866-871.
-
7Stenman UH. Tumor-associated trypsin inhibitor[J]. Clin Chem, 2002,48 : 1206-1209.
-
8Tramonti G, Ferdeghini M, Donadio C, et al. TATI and renal function[J]. Kidney Int Suppl, 1997,63 : 179-181.
-
9Venesmaa P, Stenman UH, Forss M, et al. Preoperative serum level of tumour-associated trypsin inhibitor and residual tumour size as prognostic indicators in Stage Ⅲ epithelial ovarian cancer[J]. Br J Obstet Gynaecol, 1998,105:508-511.
-
10Peter-Engl C, Buxbaum P, Ogris E, et al. TATI and CA125 in patients with early-stage endometrial cancer[JJ. Anticancer Res, 1998,18:4635-4639.
